Solutions That
Transform Care

Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.

Read more

News From Corium

Corium, Inc. Announces FDA Approval of ADLARITY® (donepezil transdermal system)

Read the Press Release
Full Prescribing Information

A PORTFOLIO COMPANY OF

Gurnet Point Capital logo
Back to top